vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and REGIS CORP (RGS). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). REGIS CORP runs the higher net margin — 0.8% vs -4.8%, a 5.6% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $891.0K). Over the past eight quarters, REGIS CORP's revenue compounded faster (7.8% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
IRWD vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $57.1M |
| Net Profit | $-2.3M | $456.0K |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 10.8% |
| Net Margin | -4.8% | 0.8% |
| Revenue YoY | -47.3% | 22.3% |
| Net Profit YoY | -200.9% | -94.0% |
| EPS (diluted) | $0.01 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $57.1M | ||
| Q3 25 | $122.1M | $59.0M | ||
| Q2 25 | $85.2M | $60.4M | ||
| Q1 25 | $41.1M | $57.0M | ||
| Q4 24 | $90.5M | $46.7M | ||
| Q3 24 | $91.6M | $46.1M | ||
| Q2 24 | $94.4M | $49.4M | ||
| Q1 24 | $74.9M | $49.2M |
| Q4 25 | $-2.3M | $456.0K | ||
| Q3 25 | $40.1M | $1.4M | ||
| Q2 25 | $23.6M | $116.5M | ||
| Q1 25 | $-37.4M | $250.0K | ||
| Q4 24 | $2.3M | $7.6M | ||
| Q3 24 | $3.6M | $-853.0K | ||
| Q2 24 | $-860.0K | $91.2M | ||
| Q1 24 | $-4.2M | $-2.3M |
| Q4 25 | 14.3% | 10.8% | ||
| Q3 25 | 61.8% | 10.0% | ||
| Q2 25 | 53.2% | 12.1% | ||
| Q1 25 | -70.7% | 8.8% | ||
| Q4 24 | 34.8% | 11.8% | ||
| Q3 24 | 28.0% | 4.6% | ||
| Q2 24 | 26.5% | — | ||
| Q1 24 | 14.7% | 8.3% |
| Q4 25 | -4.8% | 0.8% | ||
| Q3 25 | 32.8% | 2.3% | ||
| Q2 25 | 27.7% | 192.9% | ||
| Q1 25 | -90.9% | 0.4% | ||
| Q4 24 | 2.5% | 16.4% | ||
| Q3 24 | 4.0% | -1.9% | ||
| Q2 24 | -0.9% | 184.7% | ||
| Q1 24 | -5.6% | -4.7% |
| Q4 25 | $0.01 | $0.16 | ||
| Q3 25 | $0.23 | $0.49 | ||
| Q2 25 | $0.14 | $43.67 | ||
| Q1 25 | $-0.23 | $0.08 | ||
| Q4 24 | $0.03 | $2.71 | ||
| Q3 24 | $0.02 | $-0.36 | ||
| Q2 24 | $-0.01 | $38.40 | ||
| Q1 24 | $-0.03 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $-261.8M | $188.7M |
| Total Assets | $396.9M | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $18.4M | ||
| Q3 25 | $140.4M | $16.6M | ||
| Q2 25 | $92.9M | $17.0M | ||
| Q1 25 | $108.5M | $13.3M | ||
| Q4 24 | $88.6M | $10.2M | ||
| Q3 24 | $88.2M | $6.3M | ||
| Q2 24 | $105.5M | $10.1M | ||
| Q1 24 | $121.5M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | $199.5M | $111.3M | ||
| Q2 25 | $199.3M | $110.8M | ||
| Q1 25 | $199.2M | $112.0M | ||
| Q4 24 | $199.0M | $111.5M | ||
| Q3 24 | $198.8M | $95.2M | ||
| Q2 24 | $198.6M | $99.5M | ||
| Q1 24 | $398.3M | $179.7M |
| Q4 25 | $-261.8M | $188.7M | ||
| Q3 25 | $-264.2M | $187.6M | ||
| Q2 25 | $-308.2M | $185.6M | ||
| Q1 25 | $-334.1M | $68.6M | ||
| Q4 24 | $-301.3M | $66.7M | ||
| Q3 24 | $-311.3M | $56.4M | ||
| Q2 24 | $-321.7M | $56.8M | ||
| Q1 24 | $-330.5M | $-35.8M |
| Q4 25 | $396.9M | $588.3M | ||
| Q3 25 | $396.1M | $592.1M | ||
| Q2 25 | $342.9M | $599.0M | ||
| Q1 25 | $327.2M | $511.2M | ||
| Q4 24 | $350.9M | $530.1M | ||
| Q3 24 | $389.5M | $508.9M | ||
| Q2 24 | $395.6M | $530.5M | ||
| Q1 24 | $438.8M | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $1.7M |
| Free Cash FlowOCF − Capex | $74.6M | $891.0K |
| FCF MarginFCF / Revenue | 156.3% | 1.6% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $1.7M | ||
| Q3 25 | $47.6M | $2.3M | ||
| Q2 25 | $-15.1M | $6.8M | ||
| Q1 25 | $20.0M | $6.2M | ||
| Q4 24 | $15.2M | $2.1M | ||
| Q3 24 | $9.9M | $-1.3M | ||
| Q2 24 | $33.5M | $5.1M | ||
| Q1 24 | $45.0M | $-277.0K |
| Q4 25 | $74.6M | $891.0K | ||
| Q3 25 | $47.6M | $1.9M | ||
| Q2 25 | $-15.1M | $6.2M | ||
| Q1 25 | $19.9M | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $9.9M | $-1.4M | ||
| Q2 24 | $33.4M | $5.1M | ||
| Q1 24 | $44.9M | $-326.0K |
| Q4 25 | 156.3% | 1.6% | ||
| Q3 25 | 39.0% | 3.2% | ||
| Q2 25 | -17.7% | 10.3% | ||
| Q1 25 | 48.4% | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | 10.8% | -3.0% | ||
| Q2 24 | 35.4% | 10.3% | ||
| Q1 24 | 60.0% | -0.7% |
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | 1.19× | 1.68× | ||
| Q2 25 | -0.64× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | 6.74× | 0.28× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
